PharmaCampus Symposium

On February 19, 2026, the PharmaCampus Symposium was held for the second time, following its successful debut the previous year. The event once again brought together the working groups of the pharmaceutical institutes to strengthen networking and scientific exchange. This semester’s program placed particular emphasis on the presentation of ongoing research projects and interdisciplinary discussion among participants.

The symposium opened with a keynote lecture by Prof. Matthias Schiedel, who has been part of PharmaCampus since October 2025. He introduced the main research areas of his group, focusing on intracellular GPCR modulators. His talk was followed by three further presentations: Dr. Tanja Gangnus (Clinical Pharmacy) showcased in vitro strategies for characterizing the pharmacokinetic properties of novel antimalarial drug candidates. Nico Hellmund (Pharmaceutical Technology) presented the use of flow simulation to assess the emulsification process in dual centrifugation. Dr. Julian Scheiber (Pharmacology) concluded this session with an overview of the opportunities and challenges in targeting two-pore-domain potassium channels (K2P) from a pharmacological perspective.

After a short break, the focus shifted to the poster presentations. Selected highlights from the five pharmaceutical disciplines were introduced in concise poster short talks. The lecture program concluded with contributions from Anton Zürbig (Pharmaceutical Biology), who demonstrated the value of microscopic approaches in elucidating the mechanisms of action of antifungal agents, and Joana Massa (Pharmaceutical Chemistry), who presented computational studies on ion channels and their modulators.

The symposium closed with an extended poster session. Alongside presentations of current research projects from all institutes, the approximately 70 participants took the opportunity to engage in lively discussions and exchange ideas in an informal setting over snacks and refreshments.